Midwest Trust’s AstraZeneca AZN Stock Holding History

Midwest Trust’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$590K	Buy	3,113 +562	+22%	+$106K	0.01%	419
2026 Q1	$503K	Buy	+2,551	New	+$492K	0.01%	439

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Midwest Trust's AZN Position: Q2 2026 in Review

Midwest Trust increased its AstraZeneca (AZN) stake by 22% in Q2 2026, buying an estimated $106K and bringing the position to 3,113 shares worth $590K. The position accounts for 0.01% of the portfolio, ranked #419.

Midwest Trust first reported a position in AZN in Q1 2026 and has held it in 2 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Midwest Trust held 3,113 shares of AstraZeneca worth $590K as of Q2 2026.
Midwest Trust bought 562 AstraZeneca shares in Q2 2026, an estimated $106K.
AstraZeneca made up 0.01% of Midwest Trust's portfolio in Q2 2026, its #419 holding.
Midwest Trust first reported a position in AstraZeneca in Q1 2026 and has held it in 2 quarters since.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.